89 related articles for article (PubMed ID: 21189307)
1. Suppressing effects of sunitinib on allergic rhinitis: previously undefined side effects with therapeutic potential.
Eechoute K; van Zonneveld M; van Daele PL; van Wijk RG; Mathijssen RH
J Clin Pharmacol; 2011 Nov; 51(11):1592-5. PubMed ID: 21189307
[No Abstract] [Full Text] [Related]
2. Sunitinib 2 weeks on, 1 off: strengths and weaknesses.
Iacovelli R; Verri E; Cossu Rocca M; Aurilio G; Cullurà D; Nolé F
Ann Oncol; 2015 Jul; 26(7):1511-2. PubMed ID: 25846552
[No Abstract] [Full Text] [Related]
3. Alternative sunitinib schedules in metastatic renal cell carcinoma and the RAINBOW study.
Bracarda S;
Ann Oncol; 2015 Jul; 26(7):1512-3. PubMed ID: 25846555
[No Abstract] [Full Text] [Related]
4. Pazopanib outscores sunitinib on tolerability.
Cancer Discov; 2014 Jan; 4(1):OF8. PubMed ID: 24402960
[TBL] [Abstract][Full Text] [Related]
5. Renal-cell carcinoma--molecular pathways and therapies.
Brugarolas J
N Engl J Med; 2007 Jan; 356(2):185-7. PubMed ID: 17215538
[No Abstract] [Full Text] [Related]
6. Fatal liver failure in a patient treated with sunitinib for renal cell carcinoma.
Mermershtain W; Lazarev I; Shani-Shrem N; Ariad S
Clin Genitourin Cancer; 2013 Mar; 11(1):70-2. PubMed ID: 23063577
[No Abstract] [Full Text] [Related]
7. Sunitinib malate for the treatment of renal cell carcinoma.
Wood L
Expert Opin Pharmacother; 2012 Jun; 13(9):1323-36. PubMed ID: 22607009
[TBL] [Abstract][Full Text] [Related]
8. Pazopanib versus sunitinib in renal cancer.
Casper J; Schumann-Binarsch S; Köhne CH
N Engl J Med; 2013 Nov; 369(20):1969. PubMed ID: 24224638
[No Abstract] [Full Text] [Related]
9. Pazopanib versus sunitinib in renal cancer.
Wittes J
N Engl J Med; 2013 Nov; 369(20):1969. PubMed ID: 24224637
[No Abstract] [Full Text] [Related]
10. Pazopanib versus sunitinib in renal cancer.
Ramaekers R; Tharnish M; Copur MS
N Engl J Med; 2013 Nov; 369(20):1968-9. PubMed ID: 24224636
[No Abstract] [Full Text] [Related]
11. Pazopanib versus sunitinib in renal cancer.
Motzer RJ; McCann L; Deen K
N Engl J Med; 2013 Nov; 369(20):1970. PubMed ID: 24224635
[No Abstract] [Full Text] [Related]
12. Relationships between the effect of sunitinib and immature blood vessels in metastatic renal cell cancer.
Kim BH; Sohn JC; Ha JY; Park CH; Choe MS; Jung HR; Kim CI
Urol Int; 2015; 94(2):137-43. PubMed ID: 25138147
[TBL] [Abstract][Full Text] [Related]
13. Tumour lysis syndrome in a patient with renal-cell carcinoma treated with sunitinib malate.
Nicholaou T; Wong R; Davis ID
Lancet; 2007 Jun; 369(9577):1923-4. PubMed ID: 17560435
[No Abstract] [Full Text] [Related]
14. Beyond the maths of biology: long-term spontaneous tumoral regression after sunitinib withdrawal.
Teo M; Downey FP; McDermott RS
Clin Genitourin Cancer; 2013 Jun; 11(2):198-200. PubMed ID: 23276590
[No Abstract] [Full Text] [Related]
15. Sunitinib: from rational design to clinical efficacy.
Chow LQ; Eckhardt SG
J Clin Oncol; 2007 Mar; 25(7):884-96. PubMed ID: 17327610
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of sunitinib malate in second-line treatment of metastatic renal cell carcinoma in Finland.
Purmonen T; Martikainen JA; Soini EJ; Kataja V; Vuorinen RL; Kellokumpu-Lehtinen PL
Clin Ther; 2008 Feb; 30(2):382-92. PubMed ID: 18343276
[TBL] [Abstract][Full Text] [Related]
17. [Medical treatment of metastatic renal cell carcinoma after the approval and market entry of multitargeted tyrosine kinase inhibitors in Germany].
Bolenz C; Trojan L; Honeck P; Schöppler G; Herrmann E; Alken P; Michel MS; Häcker A
Aktuelle Urol; 2009 Jan; 40(1):31-6. PubMed ID: 19177319
[TBL] [Abstract][Full Text] [Related]
18. Response to sunitinib in an adult patient with rhabdoid renal cell carcinoma.
De Vincenzo F; Zucali PA; Ceresoli GL; Colombo P; Simonelli M; Lorenzi E; Perrino M; Gianoncelli L; De Sanctis R; Graziotti P; Santoro A
J Clin Oncol; 2011 Jun; 29(18):e529-31. PubMed ID: 21483010
[No Abstract] [Full Text] [Related]
19. CCR drug updates: sorafenib and sunitinib in renal cell carcinoma.
Stein MN; Flaherty KT
Clin Cancer Res; 2007 Jul; 13(13):3765-70. PubMed ID: 17606705
[No Abstract] [Full Text] [Related]
20. Direct Visualization of the Antiangiogenic Effects of Sunitinib During the Treatment of Metastatic Clear Cell Renal Cell Carcinoma.
Van Keerberghen CA; Jean-Baptiste J; Wolter P; Zucman-Rossi J; Schöffski P; Beuselinck B
Clin Genitourin Cancer; 2015 Dec; 13(6):e407-10. PubMed ID: 26026260
[No Abstract] [Full Text] [Related]
[Next] [New Search]
